Two studies measured TDP-43 in lymphoblastoid cell lines immortalized from patients with ALS and FTD due to GRN mutations, and observed increased cytoplasmic TDP-43 levels compared to healthy controls, with no differences in total TDP-43 quantity [111, 115]. This evidence concerns the gene GRN and frontotemporal dementia.